News | Proton Therapy | May 01, 2019

Pencil Beam Scanning Better Protects Children With Brain Tumors

Comparative study finds precise form of proton therapy delivers lowest dose to temporal lobes and hippocampus

Pencil Beam Scanning Better Protects Children With Brain Tumors

May 1, 2019 — A comparison of three types of radiotherapy for children's brain tumors suggests a type of proton therapy called pencil beam scanning (PBS) offers the best hope of preserving cognitive functions. The study, presented at the European Society for Radiotherapy and Oncology (ESTRO) 38 conference April 26-30 in Milan, Italy, shows this new form of radiotherapy delivers the lowest doses of radiation to the temporal lobes and hippocampus, areas of the brain important in functions like memory.

The study was presented by Laura Toussaint, a Ph.D. student at the department of Medical Physics, Aarhus University Hospital, Denmark. She said, "Brain tumors are the second most common type of cancer in children. Survival rates have increased in recent decades and currently 75 percent of children diagnosed with a brain tumor will be alive five years later.

"Alongside surgery and chemotherapy, radiotherapy plays an important role in treating brain tumors in children, but we need to protect children's developing brains from any unnecessary radiation. The more we learn about how to effectively target brain tumors while minimizing the dose to other parts of the brain, the better we can preserve children's cognitive abilities and quality of life after treatment."

Toussaint and her colleagues carried out detailed studies of 10 different children treated for brain tumors. Each child had been diagnosed with a type of cancer called craniopharyngioma, centrally located in their brain.

For each child, they planned treatments with each of the three types of radiotherapy: volumetric modulated arc therapy (VMAT), double scattering proton therapy (DSPT) or PBS proton therapy. All three are advanced radiotherapy treatments but DSPT and PBS are both types of proton therapy, which research suggests is better at targeting the tumor more precisely while sparing the surrounding tissues. However, they require expensive specific equipment that is not yet available in all hospitals. PBS is an especially precise form of radiotherapy that delivers treatment via a very narrow proton beam.

Previous research has shown that radiation doses to particular areas of the brain, including the temporal lobes and hippocampus, have an impact on children's cognitive outcomes, specifically in memory functions. Toussaint and her colleagues used these existing data to select 30 structures in the children's brains to study.

The researchers used computed tomography (CT) and magnetic resonance imaging (MRI) scans to precisely locate the structures in each of the children's brains. Then they compared the three treatment plans for each child to see which type of treatment was better at sparing those 30 structures from radiation, categorizing the dose to each structure as high, medium or low.

They found the doses to the temporal lobe were lower with the PBS treatment, compared to both the DSPT and VMAT treatments.

They found, for example, that 41 percent of the left hippocampus volume was receiving low doses of radiation with the DSPT plans, while being spared with the PBS treatment.

Using the existing data on the impacts of radiation to these regions of the brain, the researchers predict that the proton therapies, particularly the PBS treatment, would result in less impairment of the children's memory function.

Toussaint said, "We have looked at three types of radiotherapy, which all aim to successfully treat brain tumors while doing as little damage to children's brains as possible. What we found was that pencil beam scanning proton therapy seems to be by far the best at avoiding parts of the brain that are important in children's memory. The next step would be to confirm this finding with clinical research in patients.

"The use of proton therapy has been expanding rapidly over the last decade and is becoming more and more available for cancer patients, especially for children. This also means that more research can take place."

There are around 25 proton therapy centers operating in Europe, and another 19 are under construction or planned.

Prof. Umberto Ricardi, president of ESTRO and head of the Department of Oncology at the University of Turin, Italy, who was not involved in the research, said, "The aim of radiotherapy is to effectively treat cancer while causing as little damage as possible to the rest of the body. This aim could not be more important than when we are treating children's brains. Proton therapy is already being used in some hospitals to treat brain tumors in children, but this study offers evidence of the benefits it might bring in terms of protecting cognitive functions and quality of life. We hope this work will lead to more research in this vital area."

For more information: www.estro.org

Related Content

VIDEO: Advancements in Radiation Therapy for Brain Cancer

Hippocampal Sparing Prevents Whole-Brain Radiotherapy Cognitive Side Effects

Advances in Neuro-oncology

Related Content

New Data Demonstrates Safety Profile of GammaTile Therapy for Various Brain Tumors
News | Brachytherapy Systems | June 18, 2019
GT Medical Technologies Inc. announced the presentation of clinical data from a prospective study of GammaTile Therapy...
Black Men Less Likely to Adopt Active Surveillance for Low-Risk Prostate Cancer
News | Prostate Cancer | June 17, 2019
A new study reveals black men are less likely than white men to adopt an active surveillance strategy for their...
University Medical Center Groningen Performs First Automatic Log-based Proton Therapy Patient QA
News | Proton Therapy | June 14, 2019
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and...
ASTRO Applauds New Prior Authorization Legislation
News | Radiation Therapy | June 07, 2019
The American Society for Radiation Oncology (ASTRO) released a statement applauding Congress’s introduction of...
IBA Dosimetry Launches myQA iON
News | Quality Assurance (QA) | June 07, 2019
IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
RefleXion Opens New Manufacturing Facility for Biology-guided Radiotherapy Platform
News | Radiation Therapy | May 31, 2019
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward,...
AI Biomarker Demonstrates High Predictive Power for Lung Cancer Immunotherapy
News | Artificial Intelligence | May 31, 2019
Lunit announced an abstract presentation of its artificial intelligence (AI) precision medicine research portfolio at...
A set of synthetic CT images created from T1 and T2 weighted MR imaging of a prostate/rectum phantom at Henry Ford Hospital. The hospital is one of the research centers developing  synthetic CT imaging for treatment planning to avoid the need for CT scans of a patient just for treatment planning purposes when they already have a more detailed soft tissue MRI exam of  the anatomy.

A set of synthetic CT images created from T1 and T2 weighted MR imaging of a prostate/rectum phantom at Henry Ford Hospital. The hospital is one of the research centers developing synthetic CT imaging for treatment planning to avoid the need for CT scans of a patient just for treatment planning purposes when they already have a more detailed soft tissue MRI exam of the anatomy.

Feature | Radiation Oncology | May 29, 2019 | By Jeff Zagoudis
Dynamic Digital Radiography Used to Assess Undifferentiated Dyspnea
News | Digital Radiography (DR) | May 29, 2019
A clinical study presented at the American Thoracic Society (ATS) 2019 annual meeting, May 17-22 in Dallas, described...